Paliperidone palmitate vs risperidone long‐acting injection
No clinically important change Number of people whose PANSS score either increased or did not decrease by at least 30% from the beginning to the end of the trial · patients with schizophrenia
Paliperidone palmitate showed no clear difference in no clinically important change Number of people whose PANSS score… compared with risperidone long‐acting injection (low certainty).
1 finding from 1 review
- RR 1.03 [0.93, 1.14]2 studies · 1587 participantsLow